- NEGATIVE
Annual Revenue Citichem Mar-2026 Annual Revenue is Rs 15 Cr which is growth of -71.7% YoY.
- NEGATIVE
Annual Net Profit Citichem Mar-2026 Annual Net Profit is Rs 1 Cr which is growth of -18.5% YoY.
aboutCitichem India Ltd. operates within the chemicals industry, primarily focused on the trading and supply of chemical products. The company functions as an intermediary in the chemical value chain, managing the procurement and distribution of various c... Read More
16.000.50(3.23%)
2,000
BSE Volume
BSE 29 Oct, 2026 3:31 PM (IST)
Please subscribe to view forecaster data
Citichem Stock Price Analysis
Day Price Range3.2% 1 Day return | 16 (LTP) 1616 LowHigh |
|---|---|
52 Week Price Range-45.7% 1 Year return | 16 (LTP) 1231 LowHigh |
Competitors/Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Citichem annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|---|---|
-9.5% | 15.5 | 54.7 | 19.6 | 20.9 | 85.3 | ||
Operating Exp. Ann. | -12.9% | 13.5 | 52.8 | 17.8 | 20.4 | 84.8 | |
Operating Profit Ann. | 29.4% | 1.3 | 1.6 | 1.8 | 0.6 | 0.4 | |
OPM Ann. % | 45% | 8.50% | 2.95% | 9.14% | 2.79% | 0.45% | |
-11.6% | 14.1 | 53.1 | 18 | 20.4 | 85 | ||
EBITDA Ann. | 49.4% | 2 | 2 | 1.8 | 0.6 | 0.5 | |
EBITDA Ann. margin % | 67.2% | 13.04% | 3.61% | 9.14% | 2.79% | 0.52% | |
Interest Ann. | 81.7% | 0.6 | 0.3 | 0.1 | 0.1 | 0.1 | |
Depr. | - | 0.1 | 0 | 0 | 0 | 0 | |
PBT Ann. | 40.9% | 1.4 | 1.7 | 1.7 | 0.5 | 0.3 | |
Tax Ann. | 26% | 0.4 | 0.4 | 0.5 | 0.2 | 0.1 | |
35.7% | 1 | 1.2 | 1.1 | 0.4 | 0.2 | ||
Net Profit Ann. | 35.7% | 1 | 1.2 | 1.1 | 0.4 | 0.2 | |
NPM Ann. % | 57.6% | 6.77% | 2.25% | 5.70% | 1.73% | 0.28% | |
EPS Adj. latest Ann. | 44.2% | 1.5 | 1.8 | 1.6 | 0.5 | 0.4 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-71.7%
2Y CAGR
-11.1%
3Y CAGR
-9.5%
Net Profit Ann.
1Y CHG
-16.7%
2Y CAGR
-4.7%
3Y CAGR
35.7%
Operating Exp. Ann.
1Y CHG
-74.4%
2Y CAGR
-12.9%
3Y CAGR
-12.9%
Citichem Technical Analysis
Citichem EMA & SMA
Neutral0
4 bullish, 4 bearish
Bullish4
Bearish4
| 5 Day | 16.0 |
|---|---|
| 10 Day | 16.0 |
| 12 Day | 16.0 |
| 20 Day | 15.8 |
| 26 Day | 15.8 |
|---|---|
| 50 Day | 15.9 |
| 100 Day | 17.2 |
| 200 Day | 20.8 |
Citichem Delivery And Volume
Daily Avg. Delivery Volume %
29 Oct, 2026100.0%
Week100.0%
Month-
Citichem Active Candlesticks
Short Line Uptrend Tristar Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Citichem Resistance and Support
16.00
Pivot
| First Resistance | 16 |
|---|---|
| Second Resistance | 16 |
| Third Resistance | 16 |
| First Support | 16 |
|---|---|
| Second Support | 16 |
| Third Support | 16 |
| Day RSI | 51.9 |
|---|---|
| Day MACD | 0.2 |
| Day MFI | 66 |
| Day MACD Signal Line | 0.2 |
Citichem Beta
| 1 Month | -0.6 |
|---|---|
| 1 Year | -0.6 |
| 3 Month | 0.1 |
|---|---|
| 3 Year | - |
Citichem Price Change Analysis
↓0%
Over 1 Month
LowHigh
15.518.7
↑3.2%
Over 3 Months
LowHigh
12.719.9
↑8.9%
Over 6 Months
LowHigh
12.720
↓-45.7%
Over 1 Year
LowHigh
1231
Citichem Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | Purchase | 03 Jan 2025 | 69.76 | 86,000 | BSE |
Citichem Corporate Actions
Citichem Board Meetings
Citichem past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
130 May 2026 | Audited Results | - |
214 Nov 2025 | Half Yearly Results & Issue of Warrants | - |
306 Sep 2025 | Issue Of Warrants & A.G.M. | - |
430 May 2025 | Audited Results | - |
518 Mar 2025 | Half Yearly Results | - |
Citichem Corporate Filings
Citichem BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 09 Oct 2026 | Citichem India Ltd - 544324 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Compliances-Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018. | |
| 03 Oct 2026 | Citichem India Ltd - 544324 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | Scrutinizer Report with Voting Results of 34th Annual General Meeting held on 30th September, 2025. | |
| 01 Oct 2026 | Citichem India Ltd - 544324 - Announcement under Regulation 30 (LODR)-Resignation of Director | Resignation of Independent Director - Mr. Vijay Kumar Bhatt | |
| 01 Oct 2026 | Citichem India Ltd - 544324 - Clarification On Price Movement | Clarification on price movement | |
| 30 Sep 2026 | Citichem India Ltd - 544324 - Shareholder Meeting / Postal Ballot-Outcome of AGM | Proceedings of 34th Annual General Meeting of the Company held on 30th September,2026 |
Citichem - Company Profile
Citichem Management Structure
Citichem management structure with salaries, total experience, and qualifications.
Citichem Board of Directors
Citichem Board of directors with salaries, total experience, and qualifications.
Website: www.citichemindia.com
About the company - Business Profile
Citichem India Ltd. operates within the chemicals industry, primarily focused on the trading and supply of chemical products. The company functions as an intermediary in the chemical value chain, managing the procurement and distribution of various chemical substances to industrial consumers. Based in Mumbai, it maintains a market presence by leveraging its logistics and inventory management capabilities to serve a diverse range of industrial applications.
Key Points
- Key Facts:
- Headquarters: Mumbai, India.
- Stock Listing: Listed on the SME platform of the BSE (Bombay Stock Exchange).
- Core Products: Trading in a variety of chemical products (specific chemical categories are not detailed in the summary financial reports).
- Operations and Resources:
- The company operates primarily through its facility in Mumbai.
- As of September 30, 2025, tangible assets were valued at Rs. 95.62 Lakhs, showing a significant increase from Rs. 6.46 Lakhs in March 2025.
- Inventory levels stood at Rs. 867.43 Lakhs in September 2025 compared to Rs. 618.72 Lakhs in March 2025.
- Business Model and Segment Performance:
- Revenue Model: The company generates revenue through the sale of traded goods. It operates in a single reporting segment as per the financial notes.
- Financial Performance (Annual - FY2024-25):
- Total Revenue: Rs. 1,985.58 Lakhs (FY24).
- Revenue from Operations (Year Ended March 31, 2025): Rs. 5,473.47 Lakhs.
- Net Profit (Year Ended March 31, 2025): Rs. 122.87 Lakhs.
- Half-Yearly Performance (Ended September 30, 2025):
- Revenue from Operations: Rs. 1,161.70 Lakhs.
- Total Revenue: Rs. 1,316.12 Lakhs (includes Other Income of Rs. 154.42 Lakhs).
- Profit After Tax: Rs. 68.03 Lakhs.
- Geographical Concentration: Operations are primarily centered within the Indian domestic market.
- Financial Position:
- Total Equity and Liabilities: Rs. 5,776.67 Lakhs (as of September 30, 2025).
- Trade Receivables: Rs. 3,845.28 Lakhs.
- Short-term Borrowings: Rs. 699.90 Lakhs.
- Trade Payables: Rs. 2,785.51 Lakhs (predominantly to entities other than MSMEs).
- Strategic Initiatives:
- The company focuses on maintaining liquidity and managing working capital cycles, evidenced by the high volume of trade receivables and payables.
- It remains exempted from mandatory Ind AS adoption as it is listed on the SME platform, continuing to follow the Accounting Standards (AS) notified under the Companies Act, 2013.
References
